Published in Soc Neurosci on January 01, 2011
Social cognition in schizophrenia. Nat Rev Neurosci (2015) 1.15
Neural substrates of empathic accuracy in people with schizophrenia. Schizophr Bull (2012) 0.98
Common brain areas engaged in false belief reasoning and visual perspective taking: a meta-analysis of functional brain imaging studies. Front Hum Neurosci (2013) 0.96
Self-other control: a candidate mechanism for social cognitive function. Front Hum Neurosci (2014) 0.91
The neural basis of theory of mind and its relationship to social functioning and social anhedonia in individuals with schizophrenia. Neuroimage Clin (2013) 0.89
Cognitive neuroscience of human counterfactual reasoning. Front Hum Neurosci (2015) 0.81
Neural disruption to theory of mind predicts daily social functioning in individuals at familial high-risk for schizophrenia. Soc Cogn Affect Neurosci (2014) 0.79
Neural responses during social reflection in relatives of schizophrenia patients: relationship to subclinical delusions. Schizophr Res (2014) 0.76
Socio-neuro risk factors for suicidal behavior in criminal offenders with psychotic disorders. Soc Cogn Affect Neurosci (2017) 0.75
Neural Correlates of Belief and Emotion Attribution in Schizophrenia. PLoS One (2016) 0.75
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage (2002) 38.46
A global optimisation method for robust affine registration of brain images. Med Image Anal (2001) 27.87
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage (2001) 12.61
What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
Dissociable medial prefrontal contributions to judgments of similar and dissimilar others. Neuron (2006) 9.26
Finding the self? An event-related fMRI study. J Cogn Neurosci (2002) 7.99
General multilevel linear modeling for group analysis in FMRI. Neuroimage (2003) 7.79
People thinking about thinking people. The role of the temporo-parietal junction in "theory of mind". Neuroimage (2003) 7.58
Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage (2004) 6.87
Functional imaging of 'theory of mind' Trends Cogn Sci (2003) 6.31
Social cognition and the brain: a meta-analysis. Hum Brain Mapp (2009) 4.69
The functional significance of social cognition in schizophrenia: a review. Schizophr Bull (2006) 4.64
Making sense of another mind: the role of the right temporo-parietal junction. Neuropsychologia (2005) 3.81
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev (2010) 3.77
Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry (1999) 3.61
Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? J Abnorm Psychol (1993) 3.28
It's the thought that counts: specific brain regions for one component of theory of mind. Psychol Sci (2006) 3.15
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry (2005) 2.86
Social cognition in schizophrenia. Psychol Bull (1997) 2.26
Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res (2009) 2.05
Left temporoparietal junction is necessary for representing someone else's belief. Nat Neurosci (2004) 2.00
Overlapping and non-overlapping brain regions for theory of mind and self reflection in individual subjects. Soc Cogn Affect Neurosci (2006) 1.87
Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr Bull (2011) 1.77
Exploring 'theory of mind' in people with schizophrenia. Psychol Med (1996) 1.65
How we predict what other people are going to do. Brain Res (2006) 1.64
When representations conflict with reality: the preschooler's problem with false beliefs and "false" photographs. Cognition (1990) 1.61
Neural systems involved in "theory of mind". Nat Rev Neurosci (2002) 1.54
Social perception and early visual processing in schizophrenia. Schizophr Res (2003) 1.30
Mentalizing under uncertainty: dissociated neural responses to ambiguous and unambiguous mental state inferences. Cereb Cortex (2009) 1.29
Is theory of mind in schizophrenia more strongly associated with clinical and social functioning than with neurocognitive deficits? Psychopathology (2002) 1.23
Social perception in schizophrenia: the role of context. Psychiatry Res (2002) 1.22
Theory of mind impairments in schizophrenia: symptomatology, severity and specificity. Psychol Med (2001) 1.20
Exploring the social brain in schizophrenia: left prefrontal underactivation during mental state attribution. Am J Psychiatry (2000) 1.20
Theory of mind deficits for processing counterfactual information in persons with chronic schizophrenia. Psychol Med (2008) 1.18
Poor premorbid social functioning and theory of mind deficit in schizophrenia: evidence of reduced context processing? J Psychiatr Res (2005) 1.15
Abnormalities of brain function during a nonverbal theory of mind task in schizophrenia. Neuropsychologia (2003) 1.12
Dysfunction of the social brain in schizophrenia is modulated by intention type: an fMRI study. Soc Cogn Affect Neurosci (2009) 1.10
An fMRI study of theory of mind in schizophrenic patients with "passivity" symptoms. Neuropsychologia (2008) 1.08
Attribution of intentions to others in people with schizophrenia: a non-verbal exploration with comic strips. Schizophr Res (1997) 1.06
Chimpanzee problem-solving: a test for comprehension. Science (1978) 1.05
Selective impairments of theory of mind in people with schizophrenia. Schizophr Res (2001) 0.98
The predictive value of measures of social cognition for community functioning in schizophrenia: implications for neuropsychological assessment. J Int Neuropsychol Soc (2009) 0.95
Do patients with schizophrenia benefit from a self-referential memory bias? Schizophr Res (2010) 0.92
Disturbances in the spontaneous attribution of social meaning in schizophrenia. Psychol Med (2008) 0.86
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull (2005) 4.66
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res (2007) 3.79
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70
Biosocial pathways to functional outcome in schizophrenia. Schizophr Res (2005) 2.65
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry (2006) 2.42
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA Psychiatry (2013) 2.24
Nonconscious and conscious color priming in schizophrenia. J Psychiatr Res (2012) 2.08
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull (2003) 1.89
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Affective traits in schizophrenia and schizotypy. Schizophr Bull (2008) 1.81
Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res (2006) 1.80
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry (2004) 1.72
Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol (2006) 1.71
From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry (2012) 1.68
Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res (2006) 1.67
The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res (2004) 1.59
Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull (2011) 1.56
How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull (2007) 1.53
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull (2008) 1.52
Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res (2010) 1.50
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res (2008) 1.41
Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull (2011) 1.38
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophr Bull (2010) 1.36
Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry (2004) 1.33
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia. J Psychiatr Res (2009) 1.30
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Social perception and early visual processing in schizophrenia. Schizophr Res (2003) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res (2004) 1.27
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry (2011) 1.26
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull (2003) 1.24
Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res (2011) 1.20
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res (2013) 1.16
Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry (2010) 1.16
Electrophysiological correlates of emotional responding in schizophrenia. J Abnorm Psychol (2010) 1.16
The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res (2010) 1.15
Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am J Psychiatry (2013) 1.15
Emotional intelligence in schizophrenia. Schizophr Res (2008) 1.15
NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res (2004) 1.14
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology (2007) 1.13
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. Psychopharmacology (Berl) (2006) 1.13
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry (2005) 1.11
Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res (2013) 1.09
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology (Berl) (2006) 1.07
Impaired implicit learning in schizophrenia. Neuropsychology (2008) 1.07
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl) (2003) 1.06
Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychol Assess (2011) 1.05
Using event related potentials to explore stages of facial affect recognition deficits in schizophrenia. Schizophr Bull (2008) 1.04
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophr Res (2008) 1.04
Applications of errorless learning for improving work performance in persons with schizophrenia. Am J Psychiatry (2002) 1.03
Extensions of errorless learning for social problem-solving deficits in schizophrenia. Am J Psychiatry (2005) 1.02
Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol Psychiatry (2004) 1.02
Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Schizophr Res (2004) 1.02
Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophr Res (2012) 1.01
Remember and know judgments during recognition in chronic schizophrenia. Schizophr Res (2007) 1.00
Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions. Am J Psychiatry (2007) 0.99
Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophr Res (2008) 0.99
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res (2010) 0.99
Neural substrates of empathic accuracy in people with schizophrenia. Schizophr Bull (2012) 0.98
Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS. Schizophr Bull (2011) 0.98
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res (2007) 0.98
The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry (2005) 0.98
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97
A relationship between neurocognitive impairment and functional impairment in bipolar disorder: a pilot study. Psychiatry Res (2007) 0.97
Nonverbal social perception and symptomatology in schizophrenia. Schizophr Res (2002) 0.96
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry (2005) 0.96
Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology (2010) 0.96
Intact motivated attention in schizophrenia: evidence from event-related potentials. Schizophr Res (2011) 0.95
Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations. Schizophr Res (2006) 0.95
The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study. Bipolar Disord (2011) 0.94
Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? Schizophr Res (2012) 0.94
How do schizophrenia patients use visual information to decode facial emotion? Schizophr Bull (2010) 0.94
Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychol Med (2006) 0.94
Development of a measure of relationship perception in schizophrenia. Psychiatry Res (2009) 0.93
Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment. Psychiatr Clin North Am (2004) 0.93
Modulation of attention during visual masking in schizophrenia. Am J Psychiatry (2005) 0.93
Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms. Neuroimage Clin (2013) 0.93
Learning potential and the prediction of work skill acquisition in schizophrenia. Schizophr Bull (2005) 0.92
Do patients with schizophrenia benefit from a self-referential memory bias? Schizophr Res (2010) 0.92
Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res (2004) 0.92
An intact social cognitive process in schizophrenia: situational context effects on perception of facial affect. Schizophr Bull (2012) 0.92
Exploring the short term visual store in schizophrenia using the attentional blink. J Psychiatr Res (2006) 0.91
The puzzle of schizophrenia: tracking the core role of cognitive deficits. Dev Psychopathol (2012) 0.90
Increased extent of object-selective cortex in schizophrenia. Psychiatry Res (2008) 0.89
Classification of spatially unaligned fMRI scans. Neuroimage (2009) 0.89
An analysis of categorical perception of facial emotion in schizophrenia. Schizophr Res (2006) 0.89